Sera Prognostics IncNASDAQ:SERA
- LAST PRICE10.0400
- TODAY'S CHANGE (%)0.0800 (0.8032%)
- Bid / Lots8.3400/ 1
- Ask / Lots10.3000/ 5
- Open / Previous Close10.0500 / 9.9600
- Day Range
- 52 Week Range
- Volume45,381
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SERA |
|---|---|---|
| 09:32 ET | 790 | 10.16 |
| 09:34 ET | 125 | 10.05 |
| 09:36 ET | 125 | 10.05 |
| 09:45 ET | 100 | 10.17 |
| 09:50 ET | 100 | 10.175 |
| 09:59 ET | 100 | 10.14 |
| 10:03 ET | 200 | 10.14 |
| 10:06 ET | 100 | 10.145 |
| 10:17 ET | 8267 | 10.22 |
| 10:21 ET | 100 | 10.165 |
| 10:24 ET | 250 | 10.1 |
| 10:26 ET | 100 | 10.1 |
| 10:28 ET | 200 | 10.02 |
| 10:30 ET | 230 | 10.06 |
| 10:33 ET | 2285 | 9.852 |
| 10:42 ET | 181 | 9.81 |
| 10:44 ET | 100 | 9.81 |
| 10:53 ET | 403 | 9.69 |
| 11:00 ET | 890 | 9.75 |
| 11:02 ET | 200 | 9.7 |
| 11:15 ET | 100 | 9.775 |
| 11:22 ET | 100 | 9.86 |
| 11:31 ET | 100 | 9.855 |
| 11:45 ET | 700 | 9.78 |
| 11:47 ET | 100 | 9.7925 |
| 12:00 ET | 1300 | 9.76 |
| 12:05 ET | 100 | 9.785 |
| 12:07 ET | 100 | 9.7975 |
| 12:12 ET | 1500 | 9.745 |
| 12:16 ET | 100 | 9.77 |
| 12:36 ET | 100 | 9.85 |
| 12:48 ET | 100 | 9.89 |
| 12:54 ET | 213 | 9.92 |
| 12:56 ET | 320 | 9.97 |
| 12:59 ET | 100 | 9.97 |
| 01:12 ET | 100 | 9.95 |
| 01:19 ET | 200 | 9.92 |
| 01:21 ET | 100 | 9.9 |
| 01:24 ET | 100 | 9.93 |
| 01:33 ET | 106 | 9.93 |
| 01:35 ET | 200 | 9.955 |
| 01:37 ET | 100 | 10.01 |
| 01:48 ET | 100 | 10.03 |
| 01:57 ET | 190 | 9.92 |
| 02:00 ET | 100 | 10.005 |
| 02:04 ET | 510 | 9.96 |
| 02:08 ET | 100 | 9.965 |
| 02:09 ET | 100 | 10 |
| 02:15 ET | 356 | 9.92 |
| 02:18 ET | 200 | 9.945 |
| 02:22 ET | 200 | 9.975 |
| 02:29 ET | 500 | 9.975 |
| 02:33 ET | 100 | 9.995 |
| 02:38 ET | 100 | 9.995 |
| 02:44 ET | 100 | 10.01 |
| 02:49 ET | 100 | 9.98 |
| 02:56 ET | 600 | 10.01 |
| 03:07 ET | 200 | 9.91 |
| 03:14 ET | 100 | 9.96 |
| 03:16 ET | 100 | 9.95 |
| 03:23 ET | 100 | 9.96 |
| 03:30 ET | 190 | 9.97 |
| 03:32 ET | 100 | 10.005 |
| 03:38 ET | 200 | 10.005 |
| 03:41 ET | 200 | 10.06 |
| 03:45 ET | 400 | 9.985 |
| 03:48 ET | 100 | 9.9775 |
| 03:52 ET | 100 | 9.97 |
| 03:54 ET | 200 | 9.97 |
| 03:57 ET | 300 | 10.03 |
| 03:59 ET | 3128 | 10.04 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Sera Prognostics Inc | 323.0M | -8.6x | --- |
Yummies Inc | 337.2M | -5,769.2x | --- |
Healthcare Business Resources Inc | 369.0M | -56.9x | --- |
ACS Global Inc | 171.5M | 0.0x | --- |
Seafarer Exploration Corp | 140.1M | -42.0x | --- |
Taihe Group Inc | 100.0M | -1,470.6x | --- |
Company Information
Sera Prognostics, Inc. is a women's health diagnostic company utilizing its proprietary proteomics and bioinformatics platform, and significant data resources to enhance maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. It has built a proteomics and bioinformatics platform to characterize the biology of pregnancy and to discover and validate key protein biomarkers found in blood that are accurate predictors of dynamic changes that occur during pregnancy. Its commercial product, the PreTRM test, is a validated, commercially available blood-based biomarker test to predict the risk of a premature delivery, also known as preterm birth. The PreTRM test is a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation that provides a prediction of the expectant mother’s risk of delivering spontaneously before 37 weeks’ gestation.
Contact Information
- Headquarters
- 2749 E. Parleys Way, Suite 200SALT LAKE CITY, UT, United States 84109
- Phone
- 801-505-0278
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Kim Kamdar
- Chief Executive Officer, Director
- Evguenia Lindgardt
- Interim Chief Financial Officer
- Austin Aerts
- Chief Information Officer
- Robert Harrison
- Chief Scientific Officer
- John Boniface
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $323.0M |
|---|---|
Revenue (TTM) | $306.0K |
Shares Outstanding | 32.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.16 |
Book Value | $2.21 |
P/E Ratio | -8.6x |
Price/Sales (TTM) | 1,055.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -13,013.40% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
